Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB06168"
Predicate | Value (sorted: none) |
---|---|
owl:sameAs | |
drugbank:description |
"Canakinumab is a recombinant, human anti-human-IL-1β monoclonal antibody that belongs to the IgG1/κ isotype subclass. It is expressed in a murine Sp2/0-Ag14 cell line and comprised of two 447- (or 448-) residue heavy chains and two 214-residue light chains, with a molecular mass of 145157 Daltons when deglycosylated. Both heavy chains of canakinumab contain oligosaccharide chains linked to the protein backbone at asparagine 298 (Asn 298). Canakinumab binds to human IL-1β and neutralizes its inflammatory activity by blocking its interaction with IL-1 receptors, but it does not bind IL-1alpha or IL-1 receptor antagonist (IL-1ra). Canakinumab is marketed under the brand name Ilaris and indicated for patients 4 years of age and older to treat Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS), which are both part of the Cryopyrin-Associated Periodic Syndromes (CAPS) as well as for patients 2 years of age and older to treat systemic juvenile idiopathic arthritis (SJIA). Clinical trials have established the administration of canakinumab every 2 weeks to be safe and effective, offering a considerable advantage over the existing treatment with the human IL-1 receptor antagonist, anakinra, which must be injected daily and which is often poorly tolerated by patients."
|
rdf:type | |
drugbank:interactsWith | |
drugbank:interactsWith | |
drugbank:drugCategory | |
owl:sameAs | |
drugbank:interactsWith | |
drugbank:interactsWith | |
owl:sameAs | |
owl:sameAs | |
owl:sameAs | |
owl:sameAs | |
drugbank:interactsWith | |
drugbank:interactsWith | |
drugbank:drugCategory | |
owl:sameAs | |
drugbank:interactsWith | |
drugbank:interactsWith | |
drugbank:interactsWith | |
drugbank:interactsWith | |
owl:sameAs | |
owl:sameAs | |
owl:sameAs | |
rdfs:label |
"Canakinumab"
|
drugbank:interactsWith | |
owl:sameAs |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines2/drugbank_small.nt
The resource appears as object in 22 triples